Sinovac Biotech | The Business Standard
Skip to main content
  • Home
  • Economy
  • Analysis
  • Bangladesh
  • World
  • Sports
  • Glitz
  • Feature
  • Long Read
  • PSI
  • Games
  • Epaper
  • More
    • COVID-19
    • Top News
    • Companies
    • Environment
    • Infograph
    • Interviews
    • Markets
    • Special Stories
    • Multimedia/videos
    • Offbeat
    • Panorama
    • Thoughts
    • Science
    • Splash
    • Tech
    • Subscribe
    • Archive
  • বাংলা
The Business Standard
TUESDAY, APRIL 13, 2021
TUESDAY, APRIL 13, 2021
  • Home
  • Economy
  • Analysis
  • Bangladesh
  • World
  • Sports
  • Glitz
  • Feature
  • Long Read
  • PSI
  • Games
  • Epaper
  • More
    • COVID-19
    • Top News
    • Companies
    • Environment
    • Infograph
    • Interviews
    • Markets
    • Special Stories
    • Multimedia/videos
    • Offbeat
    • Panorama
    • Thoughts
    • Science
    • Splash
    • Tech
    • Subscribe
    • Archive
  • বাংলা

Sinovac Biotech

A booth displaying a coronavirus vaccine candidate from China National Biotec Group (CNBG), a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm), is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 4, 2020. REUTERS/Tingshu Wang
Coronavirus chronicle

Pakistan approves Chinese Sinopharm Covid-19 vaccine for emergency use

The authorization will be reviewed on quarterly basis for further data regarding safety, efficacy and quality

Officers carry Covid-19 vaccine amid the coronavirus disease (COVID-19) pandemic in Banda Aceh, Aceh Province, Indonesia, January 12, 2021. Ampelsa/Antara Foto via REUTERS
Coronavirus chronicle

Wariness in Indonesia as Chinese Sinovac Covid-19 jabs start

A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter
Coronavirus chronicle

Malaysia's Pharmaniaga buys 14m doses of China's Sinovac Covid vaccine

Sinovac Covid-19 vaccine. Photo/TBS
Coronavirus chronicle

Brazil health regulator says application for Sinovac vaccine lacks information

Sinovac Covid-19 vaccine. Photo/TBS
Bangladesh

Not allowing the Chinese vaccine was the wrong decision: Prof Nazrul

The question arises whether a member state would want to administer to its citizens a vaccine that has not been reviewed by EMA

Photo: Collected
World

Chinese vaccine 'successful in mid-stage trials'

Photo :Collected
Coronavirus chronicle

Chinese Covid-19 vaccine starts final tests in Brazil

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]

Copyright © 2021 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab